Document is current
Any future updates will be listed below
-
Authors
Dinesen, Sebastian https://orcid.org/0000-0002-7367-9398
Schou, Marianne G.
Hedegaard, Christoffer V.
Subhi, Yousif
Savarimuthu, Thiusius R.
Peto, Tunde
Andersen, Jakob K. H.
Grauslund, Jakob
-
Funding
Funding for this research was provided by:
Region Syddanmark (21/18139)
Steno Diabetes Center Odense (4836)
- License Information
-
More Information
Article History
Received: 14 February 2025
Accepted: 5 March 2025
First Online: 27 March 2025
Declarations
:
: Author Jakob Grauslund declares to have received speaker’s fee from Allergan, Bayer, Novartis, and Roche, and to have served as an advisory board member for Allergan, Apellis, Bayer, Novartis, and Roche, not related to this work. Author Yousif Subhi declares to have received speakers’ fee from Bayer and Roche and to be the inventor of a patent related to biomarkers for polypoidal choroidal vasculopathy. Yousif Subhi is an Editorial Board member of Ophthalmology and Therapy. Yousif Subhi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. (WO2020007612A1), not related to this work. Sebastian Dinesen, Tunde Peto, Marianne G. Schou, Christoffer V. Hedegaard, Thiusius R. Savarimuthu and Jakob K. H. Andersen declare that no conflicts of interests exist in relation to this work.
: We obtained approval for the study from the Danish Data Agency (journal number 22/9016) and the Regional Council of the Region of Southern Denmark (journal number: 23/10823). The study adhered to the tenets of the Declaration of Helsinki. The register-based data used in this study were non-identifiable.
